Gabriella Lakos

Heat shock protein 70 is a potent activator of the human complement system.

Plasmapheresis modulates Th1/Th2 imbalance in patients with systemic lupus erythematosus according to measurement of intracytoplasmic cytokines.

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

[Does the TT virus affect T-cell subgroups in patients undergoing hemodialysis?].

[Jejunal feeding in necrotizing pancreatitis or after esophagectomy].

No effect of transfusion transmitted virus viremia on the distribution and activation of peripheral lymphocytes in hemodialyzed patients.

[Evaluation of survival in mixed connective tissue disease (MCTD)].

Antiphospholipid antibodies in young women with and without oral contraceptive use.

[Antiphospholipid antibodies in acute coronary syndrome].

Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells.

Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.

[Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome].

[Primary antiphospholipid syndrome associated with HELLP syndrome in pregnancy].

Coeliac disease in Sjögren's syndrome--a study of 111 Hungarian patients.

[Combined therapy in pregnancy with primary antiphospholipid syndrome].

Relationship between skin bacterial colonization and the occurrence of allergen-specific and non-allergen-specific antibodies in sera of children with atopic eczema/dermatitis syndrome.

Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.

Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.

Features associated with epilepsy in the antiphospholipid syndrome.

Animal models of scleroderma.

Is the treatment of Hodgkin's disease detrimental to the parathyroid gland?

[Is the primary antiphospholipid syndrome a forerunner of SLE?].

[Stiff-person syndrome--two Hungarian cases and review of the literature].

Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.

Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet.

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.

Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome.

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.

Association of HELLP syndrome with primary antiphospholipid syndrome--a case report.

Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.

Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?

Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.

Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?

Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.

Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma.

Intracytoplasmic cytokine expression and T cell subset distribution in the peripheral blood of patients with ankylosing spondylitis.

Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects.

Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study.

Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.

Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.

Anti-nuscleosome antibody, a reliable indicator for lupus nephritis.

New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.

Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome.

Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.

Myth and reality: practical test system for the measurement of anti-DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE).

Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.

Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis.

Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort.

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies.

Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies.

Interference in antiphospholipid antibody assays.

Non-invasive monitoring of celiac disease: current practice and recent advances.

Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika.

Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population.

Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.

Standardization of antiphospholipid antibody testing--historical perspectives and ongoing initiatives.

Analytical and clinical comparison of two fully automated immunoassay systems for the diagnosis of celiac disease.

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.